{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:52:49Z","timestamp":1762642369049,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001829","name":"Universiteit Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jcf.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T07:38:32Z","timestamp":1590997112000},"page":"955-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation"],"prefix":"10.1016","volume":"19","author":[{"given":"Gitte","family":"Berkers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renske","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van Mourik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelotte M","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Kruisselbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia WF","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry GM","family":"Heijerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof J","family":"Majoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard H","family":"Koppelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolt","family":"Roukema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hettie M","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda B","family":"de Rijke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Marleen","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-3756","authenticated-orcid":false,"given":"Jeffrey M","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis K","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2020.04.014_bib0001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jcf.2020.04.014_bib0002","unstructured":"https:\/\/cftr2.org\/."},{"issue":"18","key":"10.1016\/j.jcf.2020.04.014_bib0003","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2020.04.014_bib0004","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2020.04.014_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(15)00201-5","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial","volume":"3","author":"Moss","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.jcf.2020.04.014_bib0006","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcf.2020.04.014_bib0007","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor\u2013Ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcf.2020.04.014_bib0008","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor\u2013Ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jcf.2020.04.014_bib0009","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"issue":"6137","key":"10.1016\/j.jcf.2020.04.014_bib0010","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jcf.2020.04.014_bib0011","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"issue":"344","key":"10.1016\/j.jcf.2020.04.014_bib0012","doi-asserted-by":"crossref","first-page":"344ra84","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.jcf.2020.04.014_bib0013","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal organoids enable personalized treatment of cystic fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jcf.2020.04.014_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02529-2017","article-title":"Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function","volume":"52","author":"de Winter-de Groot","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2020.04.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2016.04.007","article-title":"Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations","author":"Dekkers","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2020.04.014_bib0016","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bcp.2004.02.022","article-title":"The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein","volume":"67","author":"Melin","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.jcf.2020.04.014_bib0017","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1074\/jbc.M609942200","article-title":"Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"issue":"44","key":"10.1016\/j.jcf.2020.04.014_bib0018","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (Ivacaftor) opens the defective Channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.jcf.2020.04.014_bib0019","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2174\/13816128113199990320","article-title":"Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications","volume":"19","author":"Sohma","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.jcf.2020.04.014_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2011.03.001","article-title":"Curcumin and genistein additively potentiate G551D-CFTR","volume":"10","author":"Yu","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2020.04.014_bib0021","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4172\/2157-7412.1000284","article-title":"Natural compounds as therapeutic agents in the treatment cystic fibrosis","volume":"7","author":"Dey","year":"2016","journal-title":"J Genet Syndr gene Ther"},{"key":"10.1016\/j.jcf.2020.04.014_bib0022","first-page":"18825","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009"},{"key":"10.1016\/j.jcf.2020.04.014_bib0023","unstructured":"Dutch Cystic Fibrosis Foundation. Nederlandse cystic fibrosis registratie2018. 2019;"},{"issue":"3","key":"10.1016\/j.jcf.2020.04.014_bib0024","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of spirometry, 1994 update. American Thoracic Society","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2020.04.014_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rmed.2010.07.020","article-title":"Reference values for paediatric pulmonary function testing: the Utrecht dataset","volume":"105","author":"Koopman","year":"2011","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.jcf.2020.04.014_bib0026","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2020.04.014_bib0027","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jcf.2014.10.007","article-title":"A bioassay using intestinal organoids to measure CFTR modulators in human plasma","volume":"14","author":"Dekkers","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2020.04.014_bib0028","unstructured":"Summary of product characteristics - Kalydeco. 2018;1\u201376. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/kalydeco-epar-product-information_en.pdf."},{"key":"10.1016\/j.jcf.2020.04.014_bib0029","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201710-1983OC","article-title":"Effects of Lumacaftor\/Ivacaftor therapy on CFTR function in Phe508del homozygous patients with cystic fibrosis","author":"Graeber","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2020.04.014_bib0030","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1248\/bpb.34.660","article-title":"Innovative preparation of curcumin for improved oral bioavailability","volume":"34","author":"Sasaki","year":"2011","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jcf.2020.04.014_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-011-1673-1","article-title":"Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers","volume":"69","author":"Kanai","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.jcf.2020.04.014_bib0032","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-07-2693","article-title":"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects","volume":"17","author":"Vareed","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4B","key":"10.1016\/j.jcf.2020.04.014_bib0033","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"issue":"14","key":"10.1016\/j.jcf.2020.04.014_bib0034","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"04","key":"10.1016\/j.jcf.2020.04.014_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.jcf.2020.04.014_bib0036","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02850186","article-title":"Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers","volume":"22","author":"Ullmann","year":"2005","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.jcf.2020.04.014_bib0037","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-2005-864186","article-title":"Repeated oral once daily intake of increasing doses of the novel synthetic genistein product Bonistein in healthy volunteers","volume":"71","author":"Ullmann","year":"2005","journal-title":"Planta Med"},{"issue":"10","key":"10.1016\/j.jcf.2020.04.014_bib0038","first-page":"513","article-title":"Study on the pharmacokinetics of synthetic genistein after multiple oral intake in post-menopausal women","volume":"59","author":"Metzner","year":"2009","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.jcf.2020.04.014_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.maturitas.2010.11.012","article-title":"The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study","volume":"68","author":"Evans","year":"2011","journal-title":"Maturitas"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320301272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320301272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:42:50Z","timestamp":1761601370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320301272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1569199320301272"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.04.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"type":"print","value":"1569-1993"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}